Future Pharma negotiating with banks to part-finance new EGP 500 mn factory

Future Pharma Industries (FPI) is negotiating several unidentified local banks to secure funding for a new EGP 500 mn factory, CEO Gamal El Leithy told the local press. SPE Capital, which acquired a 30% stake in FPI for EGP 500 mn, will part-fund the project, he said, without providing an exact figure. The factory will produce ampoules and eye drops, and is expected to be operational by 2022.